Healthcare - Medical - Instruments & Supplies - NASDAQ - US
$ 6.85
3.63 %
$ 16.4 M
Market Cap
-0.63
P/E
BALANCE SHEET
6.22 M
ASSETS
660 K
LIABILITIES
5.56 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Innovative Eyewear, Inc.
| Current Assets | 5.62 M |
| Cash & Short-Term Investments | 4.29 M |
| Receivables | 93.2 K |
| Other Current Assets | 1.24 M |
| Non-Current Assets | 602 K |
| Long-Term Investments | 0 |
| PP&E | 133 K |
| Other Non-Current Assets | 469 K |
| Current Liabilities | 624 K |
| Accounts Payable | 582 K |
| Short-Term Debt | 0 |
| Other Current Liabilities | 42.5 K |
| Non-Current Liabilities | 35.4 K |
| Long-Term Debt | 0 |
| Other Non-Current Liabilities | 35.4 K |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| ASSETS | |||||
| Cash & Cash Equivalents | 4.3 | 3.6 | 79.7 K | 27 K | 0 |
| Short Term Investments | 0 | 0 | 0 | 0 | 0 |
| Receivables | 93.2 K | 0.1 | 43.4 K | 0 | 0 |
| Inventory | 0.9 | 94.7 K | 0.3 | 4.04 K | 0 |
| Other Current Assets | 0.4 | 0.4 | 0.2 | 25 K | 0 |
| Total Current Assets | 5.6 | 4.2 | 0.6 | 0.1 | 0 |
| PP&E | 0.1 | 0.1 | 20.3 K | 0 | 0 |
| Intangible Assets | 0.4 | 0.2 | 0.2 | 69.2 K | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 0 | 11.2 K | 20.6 K | 0 |
| Other Long Term Assets | 72.6 K | 81.8 K | 0.1 | 20.6 K | 0 |
| Other Assets | 1 | 1 | 0 | 0 | 0 |
| Total Assets | 6.2 | 4.7 | 0.8 | 0.2 | 0 |
| LIABILITIES | |||||
| Accounts Payable | 0.6 | 0.3 | 0.2 | 51.4 K | 0 |
| Short Term Debt | 0 | 61.4 K | 0.3 | 0.6 | 0 |
| Other Current Liabilities | 0 | 0.2 | 0.2 | 0.1 | 0.5 |
| Total Current Liabilities | 0.6 | 0.6 | 0.6 | 0.8 | 0.5 |
| Long Term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 0.7 | 0.7 | 0.6 | 0.8 | 0.5 |
| EQUITY | |||||
| Common Stock | 129 | 73 | 60 | 41 | 0 |
| Retained Earnings | (17.0) | (10.3) | (4.6) | (1.4) | (0.6) |
| Other Accumulative Comprehensive Income/Loss | 0 | 0 | 11.2 K | 20.6 K | 0 |
| Total Equity | 5.6 | 4.0 | 0.2 | (0.6) | (0.5) |
| Total Liabilities and Equity | 6.2 | 4.7 | 0.8 | 0.2 | 0 |
| SHARES OUTSTANDING | |||||
| Common Shares Outstanding | 0.5 | 0.3 | 0.3 | 0.1 | 6.1 |